Black tea extract delivers concentrated polyphenols in a defined dose. Strongest signal: small, consistent blood pressure drop with regular use. Habitual black tea links to modestly lower heart disease and overall death risk; lifestyle differences may contribute. Cholesterol effects mixed. Main risks: caffeine and reduced iron absorption with meals. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Systolic / Diastolic BP | Individualized; often <120/<80 mmHg | Primary intermediate outcome in black tea trials |
| LDL-C | Often <100 mg/dL; tighter if ASCVD risk high | Mixed extract/beverage lipid signal |
| ApoB | Often <90 mg/dL (stricter if high risk) | Better particle-risk marker than LDL-C alone |
| Ferritin | Context-dependent (e.g., ~50–150 ng/mL) | Tracks iron stores if tea tannins are a concern |
| Hemoglobin / CBC | Age/sex reference | Screens anemia |
| Fasting glucose or HbA1c | Glucose ~70–90 mg/dL; HbA1c often <5.5% | Optional metabolic signal |
| ALT / AST | Within lab reference | Polyphenol extract class caution |
Cadence: Baseline before relying on extract; recheck priority labs at ~8–12 weeks after stable intake, then every 6–12 months if continued long term, or sooner if medications change